A SINGLE INSTITUTIONAL EPIDEMIOLOGICAL STUDY OF PATIENTS OF NON SMALL CELL LUNG CARCINOMA WITH BRAIN METASTASIS AT PRESENTATION

Saptarshi Banerjee, Biswarup Banerjee, Srikrishna Mandal

Abstract


Brain metastasis is a dreaded complication among patients of different cancers, including lung cancer. Approximately 16 to 22% of patients with lung cancer develop brain metastases. Non small cell lung carcinoma (NSCLC) accounts for the maximum proportion of all lung cancer cases. Brain metastases during presentation carries a poorer prognosis than metachronous brain metastases in NSCLC cases. This study was aimed to retrospectively analyze the epidemiological pattern of NSCLC patients presenting with brain metastases, attending a tertiary health care centre during a period of one year. Total 22 patients, out of 198 NSCLC cases had brain metastases at presentation. There was not much difference in rate of brain metastases between male and female. Rate of brain metastases at presentation was more in case of adenocarcinoma, than in squamous cell carcinoma, though the difference was not statistically significant.

Keywords


Non small cell lung cancer, Brain metastases, Adenocarcinoma, Squamous cell carcinoma

Full Text:

PDF

References


Patel RR, Mehta MP. Targeted therapy for brain metastases: improving the therapeutic ratio. Clin Cancer Res. 2007;13:1675–1683. doi:10.1158/1078-0432.CCR-06-2489.

Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45:741–744.

Davis FG, Dolecek TA, McCarthy BJ, Villano JL. Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data. Neuro-oncology. 2012;14:1171–1177. doi:10.1093/neuonc/nos152.

Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94:2698–2705.

Ryan GF, Ball DL, Smith JG. Treatment of brain metastases from primary lung cancer. Int J Radiat Oncol Biol Phys. 1995;31:273–278. doi:10.1016/0360-3016(93)E0073-F.

Govindan R, Page N, Morgensztern D, et al.: Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24:4539–44, 2006.

Morgensztern D, Waqar S, Subramanian J, et al.: Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005. J Thorac Oncol 4:1524–9, 2009.

Lee DS, Kim YS, Kay CS, et al.: Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer. Medicine (Baltimore) 95:e2795, 2016.

Ryan GF, Ball DL, Smith JG: Treatment of brain metastases from primary lung cancer. International journal of radiation oncology, biology, physics 31:273–8, 1995.

Davis FG, Dolecek TA, McCarthy BJ, et al.: Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data. Neuro Oncol 14:1171–7, 2012.

Schouten LJ, Rutten J, Huveneers HA, et al.: Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698–705, 2002.

Gaspar L, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751.

Sperduto PW, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012;30:419–425. doi:10.1200/JCO.2011.38.0527.

Lee DS, et al. Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis. Cancer Res Treat. 2013;45:95–102. doi:10.4143/crt.2013.45.2.95.

Newman SJ and Hansen HH (1974) Proceedings: Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. Cancer 33: 492–496.

Sorensen JB, Hansen HH, Hansen M and Dombernowsky P (1988) Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 6 : 1474–1480.


Refbacks

  • There are currently no refbacks.